Skip to main content
芭薇股份 logo

芭薇股份 — Investor Relations & Filings

Ticker · 920123 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2024-09-18 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920123

About 芭薇股份

https://www.gzbawei.com/

Guangdong Bawei Biotechnology Corp., Ltd. is a comprehensive beauty and personal care solution provider specializing in research, development, production, and testing. The company offers integrated OEM, ODM, and OBM services, covering a wide range of product categories including skincare, hair care, body care, and makeup. Bawei is recognized for its commitment to scientific innovation, operating advanced R&D laboratories and an independent third-party testing center that ensures product safety and efficacy. By leveraging automated production lines and a rigorous quality management system, the company serves a diverse portfolio of domestic and international brands. Its core focus remains on delivering high-quality, customized formulations and manufacturing excellence to meet evolving consumer demands in the global beauty market.

Recent filings

Filing Released Lang Actions
关于注销部分募集资金专项账户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the cancellation of a portion of a special fundraising account. It details the background of the fundraising, the management of the funds, and the specific account closure. It references regulatory approvals and audit reports but does not contain financial statements or detailed financial performance data. The document is relatively short (1437 characters) and serves as a formal notice about the status of fundraising accounts rather than a full financial report or audit report. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2024-09-18 Chinese
投资者关系活动记录表
Investor Presentation Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details an investor relations event held on September 12, 2024, including the participation of company executives and a Q&A session about company performance and strategy. The content focuses on communication with investors regarding business outlook and financial performance, specifically addressing mid-year results and strategic responses. This matches the characteristics of an Investor Presentation (IP), which involves detailed presentations for investors focusing on financials, strategy, and market position. The document is relatively short (1177 characters) but contains substantive discussion of company strategy and financial results, consistent with an investor presentation rather than a brief announcement or regulatory filing. Therefore, the appropriate classification is Investor Presentation (IP).
2024-09-12 Chinese
关于参加广东辖区2024年投资者网上集体接待日说明会预告公告
Investor Presentation Classification · 90% confidence The document is a notice about an upcoming investor online collective reception day hosted by Guangdong Bawei Biotechnology Co., Ltd. It mentions a scheduled meeting where company directors and executives will communicate with investors about the 2024 half-year performance, governance, strategy, and sustainability. The document is an announcement of a meeting or presentation event rather than the presentation materials themselves or a detailed report. It is short (831 characters) and serves as a notice for an investor presentation event. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to a detailed presentation for investors focusing on financials, strategy, and market position, even though the actual presentation is to be held later.
2024-09-09 Chinese
湖南启元律师事务所关于广东芭薇生物科技股份有限公司2024年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a legal opinion letter issued by a law firm regarding the 2024 second extraordinary shareholders' meeting of Guangdong Bawei Biotechnology Co., Ltd. It details the legality of the meeting's convening, attendance, voting procedures, and results. The document includes specific election results for board members and amendments to the company bylaws. This type of document is a formal legal opinion on the conduct and outcomes of a shareholders' meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not a full annual or interim report, nor is it a management or audit report. It is not a proxy solicitation or a general regulatory filing. The detailed voting results and legal validation confirm it is a Declaration of Voting Results.
2024-09-03 Chinese
关于聘任公司内审部负责人的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new internal audit department head at Guangdong Bawei Biotechnology Co., Ltd. It includes details about the appointee's background and the board meeting resolution approving the appointment. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory filings beyond the appointment. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management or board members.
2024-09-03 Chinese
公司章程
Governance Information Classification · 100% confidence The document is the Articles of Association (章程) of Guangdong Bawei Biotechnology Co., Ltd. It contains detailed provisions on the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, and governance rules. It references relevant laws and regulations, including the Company Law, Securities Law, and listing rules of the Beijing Stock Exchange. The document is a comprehensive governance document that sets out the internal rules and structure of the company rather than a financial report, announcement, or other filing types. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a proxy statement or voting results announcement. It is clearly a Governance Information document detailing the company's internal rules and governance practices.
2024-09-03 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.